1) IBM-BMT
髓腔内骨髓移植
1.
On day 0 C57BL/6 (H-2b, B6) mice received sublethal dose of total body irradiation (TBI) ( 60Co γ-ray) followed by intrabone marrow -bone marrow transplatation (IBM-BMT) of 3×107cells/30 μl BMCs from BALB/c (H-2d) mice.
本研究通过非清髓性预处理方案联合髓腔内骨髓移植(IBMBMT)建立异基因小鼠免疫耐受模型,并探讨其诱导耐受的机理。
2) intra-bone marrow transplantation
骨髓腔内输注移植
3) Intra-bone Marrow
骨髓腔内
1.
Effects of Intra-bone Marrow Bone Marrow Transplantation on the Hematopoiesis in Mice;
骨髓腔内移植对异基因骨髓移植小鼠造血的影响
2.
Objective: The purposes of the experiments were to investigate the effect of bone marrow hematopoiesis in allogeneic mice after Intra-bone marrow bone marrow transplantation(IBM-BMT) and related mechanism in IBM-BMT mice.
目的:探讨骨髓腔内骨髓移植(Intra-bone marrow bone marrow transplantation, IBM-BMT)对异基因骨髓移植小鼠造血功能的影响及其可能的相关机制。
4) Bone marrow transplantation
骨髓移植
1.
Application of multiplex amplification of STRs for monitoring survival of engraftment after bone marrow transplantation;
用荧光标记短串连重复复合扩增技术监测骨髓移植存活
2.
Intestine necrosis is the primary cause of death in SCID mice with heterogeneous bone marrow transplantation;
肠坏死是异种骨髓移植后SCID鼠发生急性排斥反应死亡的主要原因
3.
Effects of the splenocytes in murine mixed bone marrow transplantation;
小鼠脾细胞在混合骨髓移植中的作用
5) Marrow transplantation
骨髓移植
1.
CD_(25)monoclonal antibody for GVHD prophylaxis in non-T-cell depleted haploidentical bone marrow transplantation for treatment of childhood leukemia;
CD_(25)抗体预防移植物抗宿主病在儿童白血病半匹配骨髓移植中的应用
2.
Nursing of intravenous ducts under collarbone in patients receiving marrow transplantation;
骨髓移植病人留置锁骨下静脉导管的护理
3.
To explore feasibility and efficacy of unrelated HLA matched donor marrow transplantation in treatment of myelodysplastic syndrome,one case (male,31 years old) of myelodysplastic syndrome-refractory cytopenia with multilineage dysplasia (MDS-RCMD) has been received unrelated HLA-matched donor transplantation.
为了探讨非亲缘HLA相合供者骨髓移植 (UD BMT)治疗骨髓增生异常综合征 (MDS)的可行治疗方案和疗效 ,采用HLA配型相合的非亲缘骨髓移植治疗 1例骨髓增生异常综合征 难治性血细胞减少伴多系病态造血(MDS RCMD)男性患者 ,31岁。
6) bone marrow transplant
骨髓移植
1.
Efficacy of splenocytes in inducing stable long-term chimerism in murine mixed haploidentical MHC matched bone marrow transplant model;
小鼠混合骨髓移植中脾细胞诱导持久稳定嵌合体的作用
2.
Objective To study the liver function of the SD rats which were ill with hepatocirrhosis after bone marrow transplant.
目的研究骨髓移植后,患肝硬化SD大鼠的肝功能的缓解情况。
3.
Objective Use a novel fluorogence quantitative PCR assay to monitor active human cytomegalovirus(HCMV) infection in the bone marrow transplant recipients.
目的用定量PCR方法监测骨髓移植患者中人巨细胞病毒 (humancytomegalovirus,HCMV)活动性感染。
补充资料：骨髓移植
| 骨髓移植 bone marrow transplantation 将正常骨髓由静脉输入患者体内，以取代病变骨髓的治疗方法。简称BMT。骨髓中有大量多能造血干细胞，具有自我复制和分化两种基本功能，在患者体内植活后，患者的造血功能和免疫功能即得以重建。 类型 根据骨髓的来源不同，BMT有3种类型：①同种异基因BMT。指人类不同个体间的移植，目前大多数BMT都指此而言，供者和受者的人类白细胞抗原(HLA）配型相合是移植成功的必要条件，亲兄弟姐妹间相合的机率是25％，无关供者相匹配的机率很少。②同基因BMT。即同卵双生子女间的BMT，效果最好。③自体BMT。即用自身的骨髓，不需供髓者，此法简便，易于推广，可广泛用于独生子女。 适应症 受者的年龄一般应小于45岁，自体BMA可高至55岁，应无重大内、外科疾病，具体适用于如下两类疾病，第一类是恶性疾病，包括：①完全缓解后的急性白血病，BMT后的5年生存率可达70％。②慢性粒细胞白血病的慢性期，80％可长期缓解或根治。③其他如难治性恶性淋巴瘤、多发性骨髓瘤、小细胞肺癌等常采用自体BMT，疗效显著。第二类是非恶性疾病如再生障碍性贫血和重症联合免疫缺陷病等。今后随着供髓者的选择、感染和移植物抗宿主病防治的解决，BMT必将被推广和显示巨大生命力。 |
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条